Quick Answer
ADMA BIOLOGICS, INC. reported Gross Profit of $292.76 million for fiscal year 2025.
ADMA BIOLOGICS, INC. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $292.76M | +33.3% |
| 2024 | $219.55M | +146.8% |
| 2023 | $88.94M | +152.2% |
| 2022 | $35.27M | +2906.4% |
| 2021 | $1.17M | +106.2% |
| 2020 | -$19.07M | -4347.0% |
| 2012 | $449.1K | -18.9% |
| 2011 | $553.5K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $75.63M | +26.8% | +12.5% |
| June 30, 2025 | $67.23M | +17.0% | +10.0% |
| March 31, 2025 | $61.10M | +56.2% | +2.4% |
| September 30, 2024 | $59.66M | +142.0% | +3.8% |
| June 30, 2024 | $57.45M | +244.2% | +46.9% |
| March 31, 2024 | $39.11M | +136.8% | +58.6% |
| September 30, 2023 | $24.65M | +155.3% | +47.7% |
| June 30, 2023 | $16.69M | +114.8% | +1.1% |
- ADMA BIOLOGICS, INC. showed an increase of +33.3% in Gross Profit compared to the prior fiscal year.
- Over the 2011–2025 period, ADMA BIOLOGICS, INC.’s gross profit has grown by 52796.1% (from $553.5 thousand to $292.76 million).
- The most recent figure is from ADMA BIOLOGICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: